ABBY MOELLER: Open Payments
NPI 1376783480 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 22 payments from 9 companies in 2025. Trend: 2023 $212 · 2024 $614 · 2025 $894
Food & beverage: $794Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $509 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $152 |
| PFIZER INC. | 3 | $72 |
| IMMUNITYBIO, INC. | 2 | $58 |
| Astellas Pharma US Inc | 1 | $26 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $21 |
| Aveo Pharmaceuticals, Inc. | 1 | $19 |
| UROGEN PHARMA, INC. | 1 | $15 |
Products named: ERLEADA, Nubeqa, RYBREVANT, XTANDI, ANKTIVA, PROLARIS, PYLARIFY, FOTIVDA.
Industry payments across OK — which companies pay providers there.
